23192 Federal Register / Vol. 74, No. 94 / Monday, May 18, 2009 / Notices 

soon as possible after the meeting, either 

by accessing the SAMHSA Committee 

Web site, https://www.nac.samhsa.gov/ 

DTAB/meetings.aspx, or by contacting 

Ms. Hersh. The transcript for the 

meeting will also be available on the 

SAMHSA Committee Web site within 

three weeks after the meeting. 

Committee Name: Substance Abuse and 

Mental Health Services Administration Drug 

Testing Advisory Board. 

Date/Time/Type: June 2, 2009 from 10 a.m. 

to 4:30 p.m. EDT: OPEN. June 3, 2009 from 

10 a.m. to 1 p.m. EDT: OPEN. 

Place: Sugarloaf and Seneca Conference 

Rooms, 1 Choke Cherry Road, Rockville, 

Maryland 20857. 

Contact: Ms. Giselle Hersh, Program 

Assistant, SAMHSA Drug Testing Advisory 

Board, 1 Choke Cherry Road, Room 2–1042, 

Rockville, Maryland 20857, Telephone: 240– 

276–2600, Fax: 240–276–2610, E-mail: 

Giselle.Hersh@samhsa.hhs.gov. 

Toian Vaughn, 

Committee Management Officer, Substance 

Abuse and Mental Health, Services 

Administration. 

[FR Doc. E9–11427 Filed 5–15–09; 8:45 am] 

BILLING CODE 4162–20–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Neurological 

Disorders and Stroke; Notice of Closed 

Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Neurological Disorders and Stroke Initial 

Review Group; Neurological Sciences and 

Disorders C. 

Date: June 8–9, 2009 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: The Fairmont Washington, DC, 2401 

M Street, NW., Washington, DC 20037. 

Contact Person: William C. Benzing, PhD, 

Scientific Review Administrator, Scientific 

Review Branch, Division Of Extramural 

Research, NINDS/NIH/DHHS/Neuroscience 

Center, 6001 Executive Boulevard, Suite 

3208, MSC 9529, Bethesda, MD 20892, (301) 

496–0660, benzingw@mail.nih.gov. 

Name of Committee: National Institute of 

Neurological Disorders and Stroke Initial 

Review Group; Neurological Sciences and 

Disorders A. 

Date: June 24, 2009 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Ritz Carlton Hotel, 1150 22nd Street, 

NW., Washington, DC 20037. 

Contact Person: Richard D. Crosland, PhD, 

Scientific Review Officer, Scientific Review 

Branch, Division of Extramural Research, 

NINDS/NIH/DHHS, Neuroscience Center, 

6001 Executive Blvd., Suite 3208, MSC 9529, 

Bethesda, MD 20892–9529, 301–496–9223. 

Name of Committee: National Institute of 

Neurological Disorders and Stroke Initial 

Review Group; Neurological Sciences and 

Disorders B. 

Date: June 25–26, 2009. 

Time: 7 a.m. to 7 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: State Plaza Hotel, 2117 E Street, 

NW., Washington, DC 20037. 

Contact Person: Ernest W Lyons, PhD, 

Scientific Review Officer, Scientific Review 

Branch, NINDS/NIH/DHHS, Neuroscience 

Center, 6001 Executive Blvd., Suite 3208, 

MSC 9529, Bethesda, MD 20892–9529, 301– 

496–4056. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.853, Clinical Research 

Related to Neurological Disorders; 93.854, 

Biological Basis Research in the 

Neurosciences, National Institutes of Health, 

HHS) 

Dated: May 12, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–11583 Filed 5–15–09; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Dental & 

Craniofacial Research; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Dental and Craniofacial Research Special 

Emphasis Panel; Review R13. 

Date: June 17, 2009. 

Time: 1 p.m. to 2 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Telephone Conference Call) 

Contact Person: Mary Kelly, Scientific 

Review Officer, Scientific Review Branch, 

National Inst. of Dental & Craniofacial 

Research, NIH 6701 Democracy Blvd., room 

672, MSC 4878, Bethesda, MD 20892–4878, 

301–594–4809, mary_kelly@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.121, Oral Diseases and 

Disorders Research, National Institutes of 

Health, HHS) 

Dated: May 11, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–11486 Filed 5–15–09; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Biomedical 

Imaging and Bioengineering; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Biomedical Imaging and Bioengineering 

Special Emphasis Panel—NIBIB Training 

2009/10. 

Date: June 26, 2009. 

Time: 11 a.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, Two 

Democracy Plaza, 6707 Democracy Blvd., 

242, Bethesda, MD 20892. (Virtual Meeting) 

Contact Person: Ruixia Zhou, Ph.D., 

Scientific Review Officer, 6707 Democracy 

Boulevard, Suite 957, Bethesda, MD 20892. 

301–496–4773. zhour@mail.nih.gov. 


cprice-sewell on PRODPC61 with NOTICES